Kristen R Szempruch

Dr. Kristen R Szempruch

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2019 in Islets
Verified
Journal Article
Closed access
KSKristen R Szempruch
Kristen R Szempruch
OBOyshik Banerjee
Oyshik Banerjee
RCRebecca Carlson
Rebecca Carlson
CDChirag S. Desai
Chirag S. Desai
Immunologic and non-immunologic loss of islet cells upon their transplantation into the liver leads to suboptimal outcomes. Anti-inflammatory agents are used during autologous and allogeneic transplantation. The aim of this qualitative systematic literature review is to evaluate their clinical use and safety. Electronic databases Embase, PubMed, Cumulative Index for Nursing and Allied Health Literature, ClinicalTrials.gov, and EU Clinical Trials Register were searched. Of the 216 unique citations, 10 with tumor necrosis factor (TNF) blockers [etanercept (ETA) or infliximab] and 3 with both TNF blockers and an interluekin-1 receptor antagonist [anakinra (ANA)]) were included. Of these, 12 were in allogeneic and one in autologous transplant. Insulin independence with decreased islet cells and number of transfusions were reported with their use. One infection was reported in a group receiving ETA. Analysis suggested that the use of ETA ± ANA have the potential to improve outcomes in islet cell transplant.

17 April 2024 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
JMJay L. Martello
Jay L. Martello
ZDZack Jules Dumont
Zack Jules Dumont
WBWiyanna Bruck
Wiyanna Bruck
MBMitchell S. Buckley
Mitchell S. Buckley
CBChristopher Buckley
Christopher Buckley
SWSharon Wu
Sharon Wu

16 January 2021 in Transplant International
Verified
Journal Article
Closed access
PDF file
CDChirag S. Desai
Chirag S. Desai
KSKristen R Szempruch
Kristen R Szempruch
JVJennifer S. Vonderau
Jennifer S. Vonderau
MCMikael Chetbourn
Mikael Chetbourn
FPFrancois Pattou
Francois Pattou
ASA. M. James Shapiro
A. M. James Shapiro
Total pancreatectomy with autologous islet cell transplant (TPAIT) is a treatment option for patients suffering from chronic or recurrent acute pancreatitis, providing benefits of pain relief, enhanced quality of life, and prevention of brittle type 3c diabetes [1]. While surgical procedure requires extensive dissection and elevates risk of bleeding [2, 3], this operation also carries potential risk of portal venous thrombosis(0.9 to 3.4%) when impure or partially purified autologous islet preparations are infused into the portomesenteric circulation[4,5]. To mitigate the risk of thrombosis and to assist with islet engraftment by reducing Instant Blood‐Mediated Inflammatory Reaction (IBMIR), anticoagulants are often utilized intra‐ and post‐operatively [6]. Through literature review and personal communications , it is clear that different centers vary in their anticoagulation practices without any consensus guideline on the type, amount, or duration of anticoagulation, nor on the type and targets for postoperative monitoring [7]. The aim of this study is to gather information about the various anticoagulation strategies utilized by programs internationally.

1 December 2020 in Transplantation Proceedings
Verified
Journal Article
Closed access
SHStephanie Heeney
Stephanie Heeney
KSKristen R Szempruch
Kristen R Szempruch
RLRuth-Ann M. Lee
Ruth-Ann M. Lee
AMAmanda Mintz
Amanda Mintz
PRPablo Serrano Rodriguez
Pablo Serrano Rodriguez
CDChristina Doligalski
Christina Doligalski

31 May 2023 in Clinical Transplantation
Verified
Journal Article
Closed access
MKMaura Kreiser
Maura Kreiser
RDRobert Dupuis
Robert Dupuis
KSKristen R Szempruch
Kristen R Szempruch
LCLaura M. Chargualaf
Laura M. Chargualaf

1 December 2021 in Transplantation Proceedings
Verified
Journal Article
Closed access
THTaylor N. Harris
Taylor N. Harris
KSKristen R Szempruch
Kristen R Szempruch
RDRobert E. Dupuis
Robert E. Dupuis
PRPablo Serrano Rodriguez
Pablo Serrano Rodriguez
ATAlexander H. Toledo
Alexander H. Toledo